The main difference between sodium rabeprazole enteric-coated tablets and capsules is that the preparations are different. Enteric-coated tablets are made by adding a layer of enteric coating to the base of the tablet, whereas capsule-filled medications are made by putting the medication into a capsule, but there is no difference in their composition or efficacy. Their main ingredient is rabeprazole sodium, and their main role is used to treat benign active gastric ulcers, active duodenal ulcers, and reflux esophagitis, anastomotic ulcers. In combination with antibiotics such as furazolidone, amoxicillin, metronidazole, and clarithromycin, it can be used to treat Helicobacter pylori infected peptic ulcers. It can also have a maintenance therapeutic effect in ulcerative or corrosive GERD’s. The use of this drug may cause adverse reactions such as thrombocytopenia, granulocyte deficiency, hemolytic anemia, and is contraindicated in patients who are allergic to rabeprazole sodium, benzimidazole substitutes, or any excipients used in the preparation of this agent. Contraindicated in pregnant and lactating women. Both rabeprazole sodium enteric-coated tablets and capsules should be taken under medical supervision.